مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,517
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

DESIGN A CHIMERIC PROMOTER CONTAINING SURVIVIN-LIKE CORE PROMOTER IN ORDER TO TRANSCRIPTIONAL TARGETING OF BREAST CANCER

Pages

  73-82

Abstract

 Objective: The greatest challenge in cancer gene therapy is to achieve the high specificity and efficiency in targeting of cancer cells. Because the goal of cancer gene therapy is to eradicate cancer cells, many therapeutic genes could be detrimental if unintentionally expressed in normal cells. Using promoter of the genes which are expressed specifically in cancer cells or have much more expression in cancer cells than normal cells, is very noticeable tool in cancer gene therapy (CGT). In this study we were searching for cancer specific promoter which could highly express therapeutic gene. Materials and methods: In order to apply a cancer specific promoter for creating a CGT construct, a promoter which has 34% similarity to Survivin core promoter was amplified from human genome by using Nested-PCR. Survivin is a member of anti-apoptotic gene and its over-expression was observed in up to 70% of breast cancers. This gene fragment contains two transcriptional binding sites which were similar to SURVIVIN PROMOTER according to the evaluation of Promoter Scan, EPD, Transfac, Compel and TRRD program. These binding sites were recognized by STAT1 and E2F transcription factors. This promoter was cloned into pCDNA3.1/Hygro+ plasmid in along with hypoxia and estrogen modules and pro-apoptotic gene tBid.Results: Semi-quantitative RT-PCR results of transfected cancer cells showed that this gene fragment (Survivin like promoter) have relatively same potential as CMV promoter to direct tBid gene expression.Conclusion: Utilization of chimeric promoter containing Survivin like promoter could be a promising tool in killing cancer cells naturally by inducing apoptosis. This construct is highly effective in TRANSCRIPTIONAL TARGETING of tBid in comparison to control construct.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    FAROKHIMANESH, S., RAHBARIZADEH, F., KAMALI, ABAS, & MOGHADAMPOUR, GH.R.. (2009). DESIGN A CHIMERIC PROMOTER CONTAINING SURVIVIN-LIKE CORE PROMOTER IN ORDER TO TRANSCRIPTIONAL TARGETING OF BREAST CANCER. PATHOBIOLOGY RESEARCH (MODARES JOURNAL OF MEDICAL SCIENCES), 12(2), 73-82. SID. https://sid.ir/paper/81306/en

    Vancouver: Copy

    FAROKHIMANESH S., RAHBARIZADEH F., KAMALI ABAS, MOGHADAMPOUR GH.R.. DESIGN A CHIMERIC PROMOTER CONTAINING SURVIVIN-LIKE CORE PROMOTER IN ORDER TO TRANSCRIPTIONAL TARGETING OF BREAST CANCER. PATHOBIOLOGY RESEARCH (MODARES JOURNAL OF MEDICAL SCIENCES)[Internet]. 2009;12(2):73-82. Available from: https://sid.ir/paper/81306/en

    IEEE: Copy

    S. FAROKHIMANESH, F. RAHBARIZADEH, ABAS KAMALI, and GH.R. MOGHADAMPOUR, “DESIGN A CHIMERIC PROMOTER CONTAINING SURVIVIN-LIKE CORE PROMOTER IN ORDER TO TRANSCRIPTIONAL TARGETING OF BREAST CANCER,” PATHOBIOLOGY RESEARCH (MODARES JOURNAL OF MEDICAL SCIENCES), vol. 12, no. 2, pp. 73–82, 2009, [Online]. Available: https://sid.ir/paper/81306/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top